Kite to Present at June 2017 Investor Conferences

SANTA MONICA, Calif.–(BUSINESS WIRE)– Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today
announced that management will present at two investor conferences in
June 2017:

• Jefferies 2017 Global Healthcare Conference
  Wednesday, June 7
  1:30pm
  Eastern Time
  New York, NY
• Goldman Sachs 38^th Annual Global Healthcare Conference
  Tuesday,
  June 13
  2:00pm Pacific Time
  Rancho Palos Verdes, CA

A live audio webcast of each event will be available on the Investors
section of Kite’s website, www.kitepharma.com.
A replay of each webcast will be available on the website for
approximately 30 days.

About Kite

Kite is a biopharmaceutical company engaged in the development of
innovative cancer immunotherapies with a goal of providing rapid,
long-term durable response and eliminating the burden of chronic care.
The company is focused on chimeric antigen receptor (CAR) and T cell
receptor (TCR) engineered cell therapies designed to empower the immune
system’s ability to recognize and kill tumors. Kite is based in Santa
Monica, CA. For more information on Kite, please visit www.kitepharma.com.
Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170606005247/en/